BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wu XR, Chen Z, Liu Y, Chen ZZ, Tang F, Chen ZZ, Li JJ, Liao JL, Cao K, Chen X, Zhou J. Prognostic signature and immune efficacy of m1 A-, m5 C- and m6 A-related regulators in cutaneous melanoma. J Cell Mol Med 2021;25:8405-18. [PMID: 34288419 DOI: 10.1111/jcmm.16800] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
Number Citing Articles
1 Yan X, Qu Y, Huang W, Zhang H, Zhu L, Zhang L. Identification and construction of a prognostic risk model based on multi-RNA methylation regulators in cervical cancer. J Obstet Gynaecol Res 2022. [PMID: 36101016 DOI: 10.1111/jog.15421] [Reference Citation Analysis]
2 Song B, Chi H, Peng G, Song Y, Cui Z, Zhu Y, Chen G, Wu J, Liu W, Dong C, Wang Y, Xu K, Yu Z, Song B. Characterization of coagulation-related gene signature to predict prognosis and tumor immune microenvironment in skin cutaneous melanoma. Front Oncol 2022;12:975255. [DOI: 10.3389/fonc.2022.975255] [Reference Citation Analysis]
3 Yang H, Messina-pacheco J, Corredor ALG, Gregorieff A, Liu J, Nehme A, Najafabadi HS, Riazalhosseini Y, Gao B, Gao Z. An integrated model of acinar to ductal metaplasia-related N7-methyladenosine regulators predicts prognosis and immunotherapy in pancreatic carcinoma based on digital spatial profiling. Front Immunol 2022;13:961457. [DOI: 10.3389/fimmu.2022.961457] [Reference Citation Analysis]
4 Xing J, Jia Z, Li Y, Han Y. Construction of immunotherapy-related prognostic gene signature and small molecule drug prediction for cutaneous melanoma. Front Oncol 2022;12:939385. [DOI: 10.3389/fonc.2022.939385] [Reference Citation Analysis]
5 Huang J, Song J, Li X, Liu S, Huang W, Shen Z, Cheng Y, Kou S, Gao Z, Tian Y, Hu J. Analysis and prognostic significance of tumour immune infiltrates and immune microenvironment of m6A-related lncRNAs in patients with gastric cancer. BMC Med Genomics 2022;15:164. [PMID: 35879790 DOI: 10.1186/s12920-022-01318-5] [Reference Citation Analysis]
6 Song B, Wu P, Liang Z, Wang J, Zheng Y, Wang Y, Chi H, Li Z, Song Y, Yin X, Yu Z, Song B. A Novel Necroptosis-Related Gene Signature in Skin Cutaneous Melanoma Prognosis and Tumor Microenvironment. Front Genet 2022;13:917007. [DOI: 10.3389/fgene.2022.917007] [Reference Citation Analysis]
7 Huang T, He WY. Construction and Validation of a Novel Prognostic Signature of Idiopathic Pulmonary Fibrosis by Identifying Subtypes Based on Genes Related to 7-Methylguanosine Modification. Front Genet 2022;13:890530. [PMID: 35754799 DOI: 10.3389/fgene.2022.890530] [Reference Citation Analysis]
8 Wang R, Guo Y, Ma P, Song Y, Min J, Zhao T, Hua L, Zhang C, Yang C, Shi J, Zhu L, Gan D, Li S, Li J, Su H. Comprehensive Analysis of 5-Methylcytosine (m5C) Regulators and the Immune Microenvironment in Pancreatic Adenocarcinoma to Aid Immunotherapy. Front Oncol 2022;12:851766. [PMID: 35433474 DOI: 10.3389/fonc.2022.851766] [Reference Citation Analysis]
9 Song H, Zhang J, Liu B, Xu J, Cai B, Yang H, Straube J, Yu X, Ma T. Biological roles of RNA m5C modification and its implications in Cancer immunotherapy. Biomark Res 2022;10:15. [PMID: 35365216 DOI: 10.1186/s40364-022-00362-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
10 Chen Y, Li H. Prognostic and Predictive Models for Left- and Right- Colorectal Cancer Patients: A Bioinformatics Analysis Based on Ferroptosis-Related Genes. Front Oncol 2022;12:833834. [PMID: 35265525 DOI: 10.3389/fonc.2022.833834] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
11 Guo L, Yang H, Zhou C, Shi Y, Huang L, Zhang J. N6-Methyladenosine RNA Modification in the Tumor Immune Microenvironment: Novel Implications for Immunotherapy. Front Immunol 2021;12:773570. [PMID: 34956201 DOI: 10.3389/fimmu.2021.773570] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
12 Zeng N, Ma L, Cheng Y, Xia Q, Li Y, Chen Y, Lu Z, Lu Q, Jiang F, Luo D. Construction of a Ferroptosis-Related Gene Signature for Predicting Survival and Immune Microenvironment in Melanoma Patients. Int J Gen Med 2021;14:6423-38. [PMID: 34675611 DOI: 10.2147/IJGM.S327348] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
13 Liu J, Zhou Z, Ma L, Li C, Lin Y, Yu T, Wei JF, Zhu L, Yao G. Effects of RNA methylation N6-methyladenosine regulators on malignant progression and prognosis of melanoma. Cancer Cell Int 2021;21:453. [PMID: 34446007 DOI: 10.1186/s12935-021-02163-9] [Cited by in F6Publishing: 2] [Reference Citation Analysis]